Recipient-related clinical risk factors for primary graft dysfunction after lung transplantation: A systematic review and meta-analysis

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Liu, Yao ^a   Liu, Yi ^a   Su, Lili ^a   Jiang, Shu Juan ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICAN AMERICAN; ARTICLE; BODY MASS; CARDIOPULMONARY BYPASS; FIBROSING ALVEOLITIS; GENDER; GRAFT RECIPIENT; HUMAN; LUNG TRANSPLANTATION; MORTALITY; PRIMARY GRAFT DYSFUNCTION; PULMONARY HYPERTENSION; RISK FACTOR; SARCOIDOSIS; SYSTEMATIC REVIEW;

FEMALE; HUMANS; LUNG DISEASES; LUNG TRANSPLANTATION; MALE; MORTALITY; ODDS RATIO; PATIENT OUTCOME ASSESSMENT; PRIMARY GRAFT DYSFUNCTION; PUBLICATION BIAS; PULMONARY WEDGE PRESSURE; RISK FACTORS;

EID: 84899122472     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0092773     Document Type: Article

References (58)

1. Arcasoy SM, Kotloff RM (1999) Lung transplantation. N Engl J Med 340:1081-1091.
2. Christie JD, Van Raemdonck D, de Perrot M, Barr M, Keshavjee S, et al ISHLT Working Group on Primary Lung Graft Dysfunction (2005) Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part I: introduction and methods. J Heart Lung Transplant 24:1451-1453. (Pubitemid 41396438)
3. King RC, Binns OA, Rodriguez F, Kanithanon RC, Daniel TM, et al. (2000) Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation. Ann Thorac Surg 69:1681-1685. (Pubitemid 30445505)
4. Christie JD, Kotloff RM, Ahya VN, Tino G, Pochettino A, et al. (2005) The effect of primary graft dysfunction on survival after lung transplantation. Am J Respir Crit Care Med 171:1312-131.
5. Lee JC, Christie JD, Keshavjee S (2010) Primary graft dysfunction: definition, risk factors, short- and long-term outcomes. Semin Resp Crit Care Med 31:161-71.
6. Barr ML, Kawut SM, Whelan TP, Girgis R, Bottcher H, et al. (2005) Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part IV: recipient-related risk factors and markers. J Heart Lung Transplant 24:1468-1482. (Pubitemid 41396441)
7. King RC, Binns OA, Rodriguez F, Kanithanon RC, Daniel TM, et al. (2000) Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation. Ann Thorac Surg 69:1681-5. (Pubitemid 30445505)
8. Thabut G, Vinatier I, Stern JB, Lesèche G, Loirat P, et al. (2002) Primary graft failure following lung transplantation: predictive factors of mortality. Chest 121:1876-82. (Pubitemid 34634409)
9. Christie JD, Kotloff RM, Pochettino A, Arcasoy SM, Rosengard BR, et al. (2003) Clinical risk factors for primary graft failure following lung transplantation. Chest 124:1232-1241. (Pubitemid 37290031)
10. Whitson BA, Nath DS, Johnson AC, Walker AR, Prekker ME, et al. (2006) Risk factors for primary graft dysfunction after lung transplantation. J Thorac Cardiovasc Surg 131:73-80. (Pubitemid 43049786)
11. Burton CM, Iversen M, Milman N, Zemtsovski M, Carlsen J, et al. (2007) Outcome of lung transplanted patients with primary graft dysfunction. Eur J Cardiothorac Surg 31:75-82. (Pubitemid 44880771)
12. Krenn K, Klepetko W, Taghavi S, Lang G, Schneider B, et al. (2007) Recipient vascular endothelial growth factor serum levels predict primary lung graft dysfunction. Am J Transplant 7:700-6. (Pubitemid 46376456)
13. Kuntz CL, Hadjiliadis D, Ahya VN, Kotloff RM, Pochettino A, et al. (2009) Risk factors for early primary graft dysfunction after lung transplantation: a registry study. Clin Transplant 23:819-30.
14. Felten ML, Sinaceur M, Treilhaud M, Roze H, Mornex JF, et al. (2012) Factors associated with early graft dysfunction in cystic fibrosis patients receiving primary bilateral lung transplantation. Eur J Cardiothorac Surg 41:686-90.
15. Fang A, Studer S, Kawut SM, Ahya VN, Lee J, et al Lung Transplant Outcomes Group (2011) Elevated pulmonary artery pressure is a risk factor for primary graft dysfunction following lung transplantation for idiopathic pulmonary fibrosis. Chest 139:782-7.
16. Allen JG, Lee MT, Weiss ES, Arnaoutakis GJ, Shah AS, et al (2012) Preoperative recipient cytokine levels are associated with early lung allograft dysfunction. Ann Thorac Surg 93:1843-9.
17. Shah RJ, Diamond JM, Lederer DJ, Arcasoy SM, Cantu EM, et al. (2012) Plasma monocyte chemotactic protein-1 levels at 24 hours are a biomarker of primary graft dysfunction after lung transplantation. Transl Res 160:435-42.
18. Samano MN, Fernandes LM, Baranauskas JC, Correia AT, Afonso JE Jr, et al. (2012) Risk factors and survival impact of primary graft dysfunction after lung transplantation in a single institution. Transplant Proc 44:2462-8.
19. Diamond JM, Lee JC, Kawut SM, Shah RJ, Localio AR, et al. (2013) Clinical risk factors for primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med 187:527-34.
20. de Perrot M, Bonser RS, Dark J, Kelly RF, McGiffin D, et al. (2005) Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part III: donor-related risk factors and markers. J Heart Lung Transplant 24:1460-1467. (Pubitemid 41396440)
21. Aeba R, Griffith BP, Kormos RL, Armitage JM, Gasior TA, et al. (1994) Effect of cardiopulmonary bypass on early graft dysfunction in clinical lung transplantation. Ann Thorac Surg 57: 715-22. (Pubitemid 24114972)
22. Shigemura N, Toyoda Y, Bhama JK, Gries CJ, Crespo M, et al. (2013) Donor smoking history and age in lung transplantation: a revisit. Transplantation 95:513-8.
23. Alvarez A, Moreno P, Illana J, Espinosa D, Baamonde C, et al. (2013) Influence of donor-recipient gender mismatch on graft function and survival following lung transplantation. Interact Cardiovasc Thorac Surg 16:426-35.
24. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, et al. (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283: 2008-2012. (Pubitemid 30214957)
25. Moher D, Cook DJ, Eastwood S (1999) Improving the quality of reports of meta-analyses of randomized controlled trials: the QUOROM statement. Quality of reporting of meta-analyses. Lancet 354: 1896.
26. Wells G, Shea B, O'Connell D, Guyatt G, Peterson J, et al. (2006) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis. Ottawa Health Research Institute (OHRI).
27. Higgins JPT, Green S, eds (2009) Cochrane handbook for systematic reviews of interventions. Version 5.0.2. New York, NY: Wiley. The Cochrane Collaboration. Available: www.cochrane-handbook.org. Accessed: 2008 June.
28. Christie JD, Carby M, Bag R, Corris P, Hertz M, et al. (2005) Report of the ISHLT working group on primary lung graft dysfunction, part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 24: 1454-9. (Pubitemid 41396439)
29. Mangialardi RJ, Martin GS, Bernard GR, Wheeler AP, Christman BW, et al. (2000) Hypoproteinemia predicts acute respiratory distress syndrome development, weight gain, and death in patients with sepsis: Ibuprofen in Sepsis Study Group. Crit Care Med 28:3137-3145.
30. Hudson LD, Milberg JA, Anardi D, Maunder RJ (1995) Clinical risks for development of the acute respiratory distress syndrome. Am J Respir Crit Care Med 151:293-301.
31. Simpson E, Scott D, Chandler P (1997) The male-specific histocompatibility antigen. Ann Rev Immunol 15:39-61.
32. Sweezey N, Tchepichev S, Cagnon S, Fertuck K, O'Brodovich H (1998) Female gender hormones regulate mRNA levels and function of the rat lung epithelial Na channel. Am J Physiol 274:379-86.
33. Hooper WC, Lally C, Austin H, Benson J, Dilley A, et al. (1999) The relationship between polymorphisms in the endothelial cell nitric oxide synthase gene and the platelet GPIIIa gene with myocardial infarction and venous thromboembolism in African Americans. Chest 116:880-886. (Pubitemid 29491853)
34. Jones DS, Andrawis NS, Abernethy DR (1999) Impaired endothelial dependent forearm vascular relaxation in black Americans. Clin Pharmacol Ther 65:408-412. (Pubitemid 29196544)
35. Kanasky WF Jr, Anton SD, Rodrigue JR, Perri MG, Szwed T, et al. (2002) Impact of body weight on long-term survival after lung transplantation. Chest 121:401-6. (Pubitemid 34132975)
36. Madill J, Gutierrez C, Grossman J, Allard J, Chan C, et al. (2001) Nutritional assessment of the lung transplant patient: body mass index as a predictor of 90-day mortality following transplantation. J Heart Lung Transplant 20:288-96. (Pubitemid 32197278)
37. Jain M, Budinger GS, Lo A, Urich D, Rivera SE, et al. (2011) Leptin promotes fibroproliferative ARDS by inhibiting peroxisome proliferator-activated receptor-γ. Am J Respir Crit Care Med 183:1490-1498.
38. Bellmeyer A, Martino JM, Chandel NS, Scott Budinger GR, Dean DA, et al. (2007) Leptin resistance protects mice from hyperoxia-induced acute lung injury. Am J Respir Crit Care Med 175:587-594. (Pubitemid 46438943)
39. Lederer DJ, Kawut SM, Wickersham N, Winterbottom C, Bhorade S, et al. (2011) Obesity and primary graft dysfunction after lung transplantation: the Lung Transplant Outcomes Group Obesity Study. Am J Respir Crit Care Med 184:1055-1061.
40. Medoff BD, Okamoto Y, Leyton P, Weng M, Sandall BP, et al. (2009) Adiponectin deficiency increases allergic airway inflammation and pulmonary vascular remodeling. Am J Respir Cell Mol Biol 41:397-406.
41. Summer R, Little FF, Ouchi N, Takemura Y, Aprahamian T, et al. (2008) Alveolar macrophage activation and an emphysema-like phenotype in adiponectin-deficient mice. Am J Physiol Lung Cell Mol Physiol 294:L1035-L1042.
42. Pierre AF, DeCampos KN, Liu M, Edwards V, Cutz E, et al. (1998) Rapid reperfusion causes stress failure in ischemic rat lungs. J Thorac Cardiovasc Surg 116:932-42. (Pubitemid 28553535)
43. Halldorsson AO, Kronon MT, Allen BS, Rahman S, Wang T (2000) Lowering reperfusion pressure reduces the injury after pulmonary ischemia. Ann Thorac Surg 69: 198-203.
44. Thabut G, Mal H, Castier Y, Groussard O, Brugière O, et al. (2003) Survival benefit of lung transplantation for patients with idiopathic pulmonary fibrosis. J Thorac Cardiovasc Surg 126:469-75. (Pubitemid 37048514)
45. Mason DP, Brizzio ME, Alster JM, McNeill AM, Murthy SC, et al. (2007) Lung transplantation for idiopathic pulmonary fibrosis. Ann Thorac Surg 84:1121-8. (Pubitemid 47417865)
46. Wahidi MM, Ravenel J, Palmer SM, McAdams HP (2002) Progression of idiopathic pulmonary fibrosis in native lungs after single lung transplantation. Chest 121:2072-6. (Pubitemid 34634439)
47. Khalil N, O'Connor R (2004) Idiopathic pulmonary fibrosis: current understanding of the pathogenesis and the status of treatment. CMAJ 171:153-60. (Pubitemid 39013268)
48. Wan S, LeClerc JL, Vincent JL (1997) Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest 112:676-92. (Pubitemid 27410703)
49. Butler J, Rocker GM, Westaby S (1993) Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 55: 552-9. (Pubitemid 23060844)
50. Aeba R, Griffith BP, Kormos RL, Armitage JM, Gasior TA, et al. (1994) Effect of cardiopulmonary bypass on early graft dysfunction in clinical lung transplantation. Ann Thorac Surg 57:715-22. (Pubitemid 24114972)
51. Gammie JS, Cheul Lee J, Pham SM, Keenan RJ, Weyant RJ, et al. (1998) Cardiopulmonary bypass is associated with early allograft dysfunction but not death after double-lung transplantation. J Thorac Cardiovasc Surg 115:990-7. (Pubitemid 28224391)
52. Christie JD, Shah CV, Kawut SM, Mangalmurti N, Lederer DJ, et al.(2009) Plasma levels of receptor for advanced glycation end products, blood transfusion, and risk of primary graft dysfunction. Am J Respir Crit Care Med 180: 1010-1015.
53. Webert KE, Blajchman MA (2003) Transfusion-related acute lung injury. Transfus Med Rev 17:252-262. (Pubitemid 37310932)
54. Wang Y, Kurichi JE, Blumenthal NP, Ahya VN, Christie JD, et al. (2006) Multiple variables affecting blood usage in lung transplantation. J Heart Lung Transplant 25:533-538.
55. Adatia I, Lillehei C, Arnold JH, Thompson JE, Palazzo R, et al. (1994) Inhaled nitric oxide in the treatment of postoperative graft dysfunction after lung transplantation. Ann Thorac Surg 57:1311-1318. (Pubitemid 24204526)
56. Macdonald P, Mundy J, Rogers P, Harrison G, Branch J, et al. (1995) Successful treatment of life-threatening acute reperfusion injury after lung transplantation with inhaled nitric oxide. J Thorac Cardiovasc Surg 110:861-863.
57. Garat C, Jayr C, Eddahibi S, Laffon M, Meignan M, et al. (1997) Effects of inhaled nitric oxide or inhibition of endogenous nitric oxide formation on hyperoxic lung injury. Am J Respir Crit Care Med 155: 1957-1964. (Pubitemid 27256125)
58. Shargall Y, Guenther G, Ahya VN, Ardehali A, Singhal A, et al. (2005) Report of the ISHLT working group on primary lung graft dysfunction: Part VI. Treatment. J Heart Lung Transplant 24:1489-1500. (Pubitemid 41396443)